SCHEMBL4606740

SCHEMBL4606740

COC(=O)C1=NN(c2ccc(Cl)cc2Cl)C(c2ccc(Cl)s2)C1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 9/20 0.46
CNR2 P34972 9/20 0.46
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
EGFR P00533 2/20 0.36
KDR P35968 2/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
S1PR4 O95977 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14621419 1.00 CNR1 (0.46) CNR1CNR2KDM4EGAAALDH1A1
SCHEMBL4606992 0.90 CNR1 (0.45) CNR1CNR2KDM4EGAAALDH1A1
SCHEMBL4604690 0.89 EGFR (0.44) CNR1CNR2KDM4EALDH1A1GABRA2
SCHEMBL4604890 0.87 CNR1 (0.47) CNR1CNR2GABRA2GABRB2
SCHEMBL4607493 0.87 CNR1 (0.47) CNR1CNR2
SCHEMBL4607069 0.85 CNR1 (0.41) CNR1CNR2
SCHEMBL4606907 0.84 CNR1 (0.46) CNR1CNR2KDM4EGAAALDH1A1
SCHEMBL2021240 0.84 CNR1 (0.63) CNR1CNR2KDM4EGAAALDH1A1
SCHEMBL14621436 0.84 CNR1 (0.63) CNR1CNR2KDM4EGAAALDH1A1
SCHEMBL4607499 0.82 CNR2 (0.46) CNR1CNR2ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP claimed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP claimed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP claimed
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
WO-2007009690-A1 HETEROCYCLYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A (ES) 2007-01-25 WO disclosed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed